PACULit Literature Updates August 2025: Pediatrics Dupilumab Plus Medium-Dose Inhaled Corticosteroid ICS Improves Outcomes Compared With Placebo Plus Continued HighDose ICS in Children With Uncontrolled ModeratetoSevere Type 2 Asthma Lesson Content 0% Complete 0/1 Steps Dupilumab Plus MediumDose Inhaled Corticosteroid ICS Improves Outcomes Compared With Placebo Plus Continued HighDose ICS in Children With Uncontrolled ModeratetoSevere Type 2 Asthma Dupilumab Plus Medium-Dose Inhaled Corticosteroid ICS Improves Outcomes Compared With Placebo Plus Continued HighDose ICS in Children With Uncontrolled ModeratetoSevere Type 2 Asthma Previous Lesson Back to Course Next Lesson
